Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Join us on Tuesday 4 June for an exclusive drinks reception and panel event featuring some of the UK’s top former and current sports professionals living with type 1 diabetes.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Join the type 1 diabetes community and come together, raising awareness and vital funds for T1D.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
JDRF has now rebranded to Breakthrough T1D. Our name has changed, our mission has not.
Home > How to help > Take part in type 1 diabetes research > Take part in type 1 diabetes clinical trials
Clinical trials are research studies that test any kind of treatment in people to find out if they are safe and effective. There are three stages of clinical trials, each involving more participants. They are a crucial step in the research pipeline that can only happen once a treatment has been thoroughly tested in cells and animals in the lab, which are known as preclinical trials.
You can learn more about clinical trials on the government’s clinical trials website.
Volunteering to be part of research is a tremendous help to type 1 diabetes researchers. Without volunteers taking part in these studies, it would not be possible to develop any new therapies for type 1.
If you have recently been diagnosed with type 1 diabetes, you could help researchers test several different treatments and their ability to preserve beta cell function.
To learn more, see the current trial sites available, and get involved please visit the T1D Plus website.
Please be aware that more sites will become available, so please check back in each month.
If you live with type 1 diabetes and heart failure symptoms, you could help researchers understand if a tablet, called sotagliflozin, could improve the quality of live in people with type 1 diabetes and heart failure.
To learn more, see the current trial sites available, and express your interest in taking part in the trial, please fill out our Expression of Interest form.
Please be aware that more study sites will become available, so please check back in each month.
If you can’t find anything suitable from the above opportunity(ies) or the clinical trial finder below, you could ask your doctor if they know of any studies which might be appropriate for you. You can also have a look at the National Institute of Health Research (NIHR) Be a part of Research website to search for current type 1 diabetes clinical trials.
Clicking the tool below will take you to the Antidote website, a digital health company who created and support this tool. You will be asked several questions about you and your health to search which clinical trials you may be able to take part in.
“People like Daisy who are taking part in trials now will make living with type 1 easier for themselves and others in the future. It’s about everyone doing a little bit and being part of something so important.”
The UK T1D Research Consortium is funded by Breakthrough T1D UK and Diabetes UK. It is a platform recruiting volunteers to join clinical trials of new immunotherapies for type 1.
INNODIA is a platform that recruits Europeans under 45 who were either diagnosed with type 1 in the last six weeks or have a close relative with type 1. They do blood tests to show who is likely to later develop type 1 and invite them to take part in clinical trials of possible treatments.
ADDRESS-2 supports research involving people with type 1 diabetes who want to take part, from the moment they are diagnosed. They help connect people diagnosed in the last six months with researchers running clinical trials.
